PNMA6E

Model summary

A soluble human regulatory scaffold that uses two Ma-like binding modules to assemble inhibitory complexes that dampen RNA polymerase II–driven transcription. It predominantly operates in the nucleoplasm and cytosol, where it stabilizes repressor assemblies and modulates gene expression, with transient association to membrane-proximal compartments and occasional extracellular exposure. Its mechanism relies on multivalent protein binding that nucleates chromatin-regulatory assemblies to achieve transcriptional repression.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The polypeptide starts with IPR048271 (Paraneoplastic antigen Ma-like, N-terminal domain, residues 1–92), proceeds through a long central region, and ends with IPR048270 (Paraneoplastic antigen Ma-like, C-terminal domain, residues 324–485). The entire sequence is encompassed by IPR026523 (Paraneoplastic antigen Ma family, residues 1–635). This bipartite Ma-like architecture—an N-terminal module followed by a C-terminal module separated by an extended linker—defines a soluble, non-enzymatic scaffold typical of the Ma/PNMA family. The absence of catalytic signatures and the presence of two structured binding modules causally point to multivalent macromolecular interactions rather than enzymatic chemistry, supporting a primary molecular function of GO:0005515 protein binding.

2. 02

   From this binding-centric core, I infer regulatory roles that require dynamic assembly with nuclear and cytosolic partners.

   The nucleoplasmic presence (GO:0005654 nucleoplasm) and soluble nature of the Ma-like scaffold together create a platform for transcriptional control. Such scaffolds often repress by recruiting chromatin-modifying or transcriptional repressor assemblies to RNA polymerase II-regulated loci. This mechanistic logic—multivalent binding that nucleates repressor complexes at promoters or enhancers—maps directly to GO:0000122 negative regulation of transcription by RNA polymerase II. The same modular architecture that stabilizes transcriptional repression in the nucleus can also operate in the cytosol to tune availability and trafficking of regulatory factors that feed back to transcription.

3. 03

   Cellular localization follows from these inferences and the domain layout.

   The soluble Ma-like scaffold explains residence in the GO:0005829 cytosol and GO:0005654 nucleoplasm. The additional GO:0016020 membrane and GO:0005576 extracellular region suggest peripheral association with membranes and unconventional secretion or surface exposure. The lack of transmembrane domains argues that membrane association is indirect—likely via transient binding to membrane-proximal complexes or vesicular pathways—consistent with a cytosolic/nuclear core that can transiently sample membrane-associated compartments and be released extracellularly.

4. 04

   Integrating these layers yields a coherent mechanism: the N- and C-terminal Ma-like domains create a two-headed binding platform that assembles transcriptional repressor complexes in the nucleoplasm, thereby dampening RNA polymerase II-driven gene expression.

   Cytosolic pools likely coordinate with signaling and trafficking machinery that modulate nuclear access and membrane-proximal assemblies. This architecture and localization together predict interactions with nuclear repressors and chromatin regulators and explain how a predominantly soluble scaffold can exert nuclear repression while sampling cytosolic and membrane-associated environments.

5. 05

   I therefore hypothesize that the protein forms inhibitory assemblies with transcriptional repressors and chromatin remodelers in the nucleoplasm, while cytosolic and membrane-proximal contacts tune its availability and may facilitate occasional extracellular presentation.

   Likely partners include RNA polymerase II-associated repressors and corepressor complexes that operate at promoter-proximal sites, consistent with its role in negative transcriptional regulation and its multi-compartment distribution.